Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News

Fecal microbiota transplant may help patients with IBS and depressive symptoms

A meta-analysis of randomized trials suggests fecal microbiota transplantation can ease depressive symptoms, with stronger effects reported for endoscopic or enema delivery, according to researchers at the Department of Nursing, ...

Gut microbiome affects alcohol preference by influencing brain's reward system

Researchers at Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences have found a surprising connection between a fungus associated with alcohol use disorder and the brain's dopamine reward ...

Comparing behavioral approaches for irritable bowel syndrome

Researchers led by Wake Forest University School of Medicine and Atrium Health have judged the certainty of evidence on behavioral therapies for irritable bowel syndrome to be low to very low as many published trials show ...

Scientists identify markers of key stem cell populations driving colorectal cancer formation

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified markers of two critical stem cell populations that drive colorectal cancer formation.

Challenges seen in diagnosing UTI in children with neurogenic bladder

Most children with neurogenic bladder (NGB) and diagnosed with febrile urinary tract infection (UTI) in the emergency department (ED) did not meet a commonly recommended definition for UTI, according to a study published ...

New insights into the role of stellate cells and blood vessels in the aging pancreas

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive disorders, and also cancer. Researchers at the German Institute of Human Nutrition Potsdam-Rehbruecke ...

Todays Updates

mRNA-based COVID vaccines generate improved responses to immunotherapy

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

Todays Updates

mRNA-based COVID vaccines generate improved responses to immunotherapy

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

Latest News

A meta-analysis of randomized trials suggests fecal microbiota transplantation can ease depressive symptoms, with stronger effects reported for endoscopic or enema delivery, according to researchers at the Department of Nursing, ...

Researchers at Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences have found a surprising connection between a fungus associated with alcohol use disorder and the brain's dopamine reward ...

Researchers led by Wake Forest University School of Medicine and Atrium Health have judged the certainty of evidence on behavioral therapies for irritable bowel syndrome to be low to very low as many published trials show ...

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified markers of two critical stem cell populations that drive colorectal cancer formation.

Most children with neurogenic bladder (NGB) and diagnosed with febrile urinary tract infection (UTI) in the emergency department (ED) did not meet a commonly recommended definition for UTI, according to a study published ...

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive disorders, and also cancer. Researchers at the German Institute of Human Nutrition Potsdam-Rehbruecke ...

News All Time

Microplastics found to change gut microbiome in first human-sample study

New research presented at UEG Week 2025 shows that microplastics—plastic particles smaller than 5 mm commonly found in the environment—can alter the human gut microbiome, with some changes resembling patterns linked to ...

Colon cancer considered cured after six years when relapse risk falls below 0.5%

IRCCS Ospedale Policlinico San Martino with Mayo Clinic and multiple international cancer research centers have delivered a pooled analysis indicating that colon cancer recurrence risk drops below 0.5% by year six after surgery, ...

'Good' gut bacteria can boost placenta for healthier pregnancy

Research led by the University of Cambridge has found the first clear evidence that the "good" gut bacteria Bifidobacterium breve in pregnant mothers regulates the placenta's production of hormones critical for a healthy ...

Rectal bleeding in young adults linked to 8.5 times higher risk of colorectal cancer

Adults under 50 undergoing colonoscopy were found to have a dramatically higher risk of having colorectal cancer when the procedure was done for rectal bleeding. Researchers found that rectal bleeding increased the odds of ...

Novel antibiotic targets IBD—and AI predicted how it would work before scientists could prove it

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases ...

Significant global variation found in treatment of common bowel condition

The treatment of a common bowel condition, diverticulitis varies widely across the world. In particular the use of antibiotics is "alarmingly high" according to the biggest data analysis of the disease to date published in ...

Five herbs and spices that could help improve your digestion

Digestive discomfort—whether it's bloating after a heavy meal or the occasional bout of indigestion—can make anyone miserable.

Widespread presence of threadworm suggests other forgotten diseases may be making a comeback

USC researchers have found evidence of threadworm (Strongyloides stercoralis) in South Carolina in two different studies. Their research, which was published in The American Journal of Tropical Medicine and Hygiene, was led ...

Tumor cells can exploit damaged tissue in the pancreas to create new environments for growth

Pancreatic cancer is an aggressive disease, and unlike many other cancers, survival rates have barely improved. Researchers at Karolinska Institutet, in collaboration with the Department of Pathology at Karolinska University ...

Getting more fiber into British diets will take teamwork and guts

British adults eat just 18g of dietary fiber daily, far below the recommended 30g, putting millions at risk of developing heart disease, type 2 diabetes, and colorectal cancer.

Recommendations issued for diagnosing, managing gastroparesis

In a clinical practice guideline issued by the American Gastroenterological Association and published in the October issue of Gastroenterology, conditional recommendations are presented for the diagnosis and management of ...

Study links food and beverage temperature to mental and gut health

Be it a cool iced coffee or warm cup of soup, the temperature of what we eat and drink may influence our mental and digestive health, according to new research led by San Diego State University.

A2 milk is not always the best option for milk-sensitive individuals, study suggests

A recent Finnish study investigated the effects of A2 milk, marketed as a gut-friendly alternative, and protein-hydrolyzed lactose-free milk on gastrointestinal symptoms and inflammation levels. The study found that protein-hydrolyzed ...

What the gut microbiome of the world's oldest person can tell us about aging

When María Branyas Morera died in 2024 at the age of 117, she left more than memories. She left science a gift: samples of her microbiome.

Tackling inflammation in the gut: The role of 'unconventional' immune cells

Immune cells called double negative T cells are abundant in the intestine but have been poorly understood till date. In a recent study, researchers from the Institute of Science Tokyo report that these cells actually have ...

Donor milk storage key to preemie gut health

Odds are that when you go to the supermarket, you check each product you pick up for its "best by" date, ensuring that you have the freshest, healthiest food to bring home for you and your family. An MUSC study published ...

Recommended News For You

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

Recommended Articles For You

Understanding Apoplexy: Symptoms, Causes, and Treatment Options  

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging 

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology 

Understanding Lymphedema: Symptoms, Causes, and Treatment  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

2.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.

3.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

4.

A study on lung cancer provides additional proof of the value of screening.

5.

Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco

1.

The Latest Advances in Glioblastoma Treatment and Prevention 

2.

Beyond Immunotherapy: Emerging Novel Treatments for Small Cell Lung Cancer

3.

Exploring the Latest Treatments for Essential Thrombocythemia

4.

Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods

5.

Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part VIII

2.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot